Desitin


Also found in: Wikipedia.

Desitin

(dĕs′ĭ-tn)
A trademark for an over-the-counter ointment containing zinc oxide.
References in periodicals archive ?
Major Products: Johnson's, Penaten and Desitin baby care products; Aveeno, Clean & Clear, Johnson's, Neutrogena, Le Petit Marseillais beauty products.
A generic Zinc oxide ointment and Desitin had also been used throughout the course of her wound care, for which she thought made her condition worse.
9% Leading brands Dollar sales % Market In drugstores (000) change share Desitin Maximum Strength $9,240 - 0.
Szeimies is an adviser for Almirall, Biofrontera, Galderma, and Pierre Fabre Dermo Cosmetique, France, and is a member of the speakers bureau for Almirall, Desitin, Galderma, Janssen, Pierre Fabre Dermo Cosmetique, France.
Johnson & Johnson maintains its leading position, holding a 16% retail value share through its diverse portfolio of leading brands in several dermatological sub-categories: Neutrogena T/Gel in medicated shampoos, Rogaine in hair loss treatments, Desitin in nappy (diaper) rash treatments, Aveeno in antipruritics, Tucks in haemorrhoid treatments, Benadryl in topical allergy remedies/antihistamines and Neosporin in topical germicidals/antiseptics.
McNeil Consumer Healthcare maintained 20% value share in 2014, with well-known brands like Anusol, Polysporin, Rogaine, Desitin, and Benadryl, each of which is typically among the top three brands in its respective area.
The cities of Desitin, Fort Walton Beach, Santa Rosa, and Panama City Beach are also included in the treatment area.
Holtkamp disclosed that he has received funds from several pharmaceutical companies, including Desitin, GlaxoSmithKline, UCB, and others.
Major Products: Baby, skin care and oral product brands including Aveeno, Neutrogena, Lubriderm, Clean & Clear, johnson's Baby, Desitin, Listerine, RoC.
David Trevor, managing director for Desitin UK, said, 'Veeva was recommended to me by a trusted third party so I took a look.
Aaccording to the distribution agreement between the two companies Desitin Arzneimittel GmbH has today started the distribution of AmeluzA in Denmark, Norway and Sweden.
Zogenix has a partnership with Desitin Arzneimittel GmbH to develop and commercialize SUMAVEL DosePro in the European Union (EU).